Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03135327 · ClinicalTrials.gov registry record · NA
Clinical Applications of Advanced Ophthalmic Imaging
A NA study of Multiple Sclerosis and Dementia, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 5,000
- Enrollment target
- 1
- Study location
NCT03135327: Recruiting NA study of Multiple Sclerosis and Dementia, sponsored by University of Miami.
NCT03135327 is a NA study of Multiple Sclerosis and Dementia that is actively recruiting participants, run by University of Miami. The registered enrollment target is 5,000 participants, above the 569-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (779% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03135327, a NA study of Multiple Sclerosis and Dementia, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The first phase is an observational phase which studies the eye in various conditions. The second phase is an interventional phase which studies the changes in the eyes after taking an over-the-counter medical food (Ocufolin) for 6 months.
Primary Outcome
Optical coherence tomography is used to measure the thickness of intraretinal layers. The measurement is in micrometer.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Ocufolin
Study Locations (1)
Florida
- Bascom Palmer Eye Institute - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2007-01-01 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT03135327 shows while recruiting
NCT03135327 is an interventional study that assigns participants to a tested intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 569-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (779% higher).
The record links to 6 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Ocufolin is the first listed.
NCT03135327 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03135327 about?
NCT03135327 is a clinical study titled "Clinical Applications of Advanced Ophthalmic Imaging". The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The firs...
What is the current status of trial NCT03135327?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,000 participants. The study started on 2007-01-01. Estimated completion is 2029-12-31.
What conditions does trial NCT03135327 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Dementia, Myopia, Diabetic Retinopathy, Presbyopia.
What interventions are being tested in trial NCT03135327?
The interventions under investigation include: Ocufolin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03135327?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03135327 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03135327's enrollment target sits among peer trials
5,000 6th of 315 higher than 309 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Central Vein Sign in Multiple Sclerosis Extension Study
RECRUITING · NA
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI